About
Seer is pioneering next-generation proteomics technology through its flagship Proteograph Product Suite, designed to deliver deep, rapid, and unbiased protein profiling at scale. The platform addresses a longstanding challenge in life sciences: the inability to comprehensively and efficiently analyze the proteome the way genomics tools analyze the genome. Seer's novel nanoparticle-based technology provides a new lens on the proteome, enabling researchers to detect low-abundance proteins that play critical roles in disease and health states. The Proteograph Analysis Suite complements the hardware platform with an intuitive software interface for quickly and accurately analyzing complex proteomic data, investigating biology, and discovering new biomarkers. Seer also maintains a Protein Discovery Catalog featuring more than 36,000 definitively identified multi-species proteins, serving as a valuable reference resource for the research community. Seer's Technology Access Center offers white-glove service programs for institutions that want expert-guided access to the platform. The company supports a global network of service providers and provides extensive training, user guides, and technical support through its customer portal. Seer is particularly well-suited for academic research institutions, NCI-designated cancer centers, and biomedical research organizations looking to improve plasma proteomics coverage, throughput, and reproducibility. It is an ideal solution for proteogenomics, biomarker discovery, and large-scale clinical research studies.
Key Features
- Proteograph Product Suite: A novel nanoparticle-based hardware platform for deep, rapid, and unbiased proteomic profiling at scale, enabling detection of low-abundance proteins critical to disease research.
- Protein Discovery Catalog: A growing reference catalog of 36,000+ definitively identified multi-species proteins, searchable and accessible to support proteomics and genomics research.
- Proteograph Analysis Suite: An intuitive software platform for quickly analyzing proteomics data, investigating complex biology, and discovering new biomarkers with improved visual contrast and workflow tools.
- Technology Access Center: White-glove service programs that give research institutions guided access to Seer's platform with expert support and hands-on training.
- Global Service Provider Network: A worldwide network of certified service partners enabling broad access to Seer's proteomics technology across research institutions globally.
Use Cases
- Plasma proteomics research at cancer research centers seeking deeper protein coverage and higher throughput
- Biomarker discovery for disease diagnosis and therapeutic development in clinical proteomics studies
- Proteogenomics research integrating protein and genomic data for comprehensive biological insights
- Large-scale multi-cohort proteomics studies requiring reproducible, unbiased sample analysis
- Academic research labs exploring low-abundance protein biology in health and disease contexts
Pros
- Unbiased, Deep Proteome Coverage: Seer's platform enables comprehensive detection of low-abundance proteins that other technologies miss, providing a panoramic view of the proteome.
- High Throughput and Reproducibility: The Proteograph platform is designed for large-scale studies with consistent, reproducible results, making it suitable for clinical and translational research.
- Integrated Hardware and Software: The combination of the Proteograph instrument and Analysis Suite creates an end-to-end workflow from sample preparation to data insights.
- Extensive Scientific Validation: The platform has been featured in numerous peer-reviewed publications, validating its utility and credibility in the research community.
Cons
- Enterprise-Level Cost: As a premium laboratory platform, Seer's products are likely cost-prohibitive for smaller research labs or independent researchers without institutional funding.
- Requires Specialized Laboratory Setup: The Proteograph Product Suite is hardware-based and requires proper lab infrastructure, limiting accessibility to well-equipped institutions.
- Steep Learning Curve: Proteomics is a complex domain, and maximizing the platform's potential may require specialized training and expertise in mass spectrometry or proteomics workflows.
Frequently Asked Questions
What is the Proteograph Product Suite?
The Proteograph Product Suite is Seer's flagship platform for deep, rapid, and unbiased proteomics research at scale. It uses a novel nanoparticle-based technology to provide comprehensive coverage of the proteome, including low-abundance proteins often missed by other methods.
What is the Protein Discovery Catalog?
The Protein Discovery Catalog is a searchable database of over 36,000 definitively identified multi-species proteins detected using Seer's technology. It serves as a reference resource for proteomics and genomics researchers worldwide.
Who is Seer's platform designed for?
Seer's platform is designed for academic research institutions, cancer research centers, biotech and pharma companies, and clinical researchers engaged in proteomics, biomarker discovery, and proteogenomics.
Does Seer offer a software-only solution?
Yes, the Proteograph Analysis Suite is Seer's software component that allows researchers to quickly and accurately analyze proteomics data, investigate complex biology, and discover new biomarkers independently of the hardware.
How can I access Seer's technology without purchasing the hardware?
Seer offers a Technology Access Center with white-glove service programs, and maintains a worldwide network of service provider partners, enabling researchers to access the platform through external labs and collaborators.
